You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Dual inhibitor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type 2 Diabetes Trial in Seoul (SGLT2 inhibitor)

Not yet recruiting
  • Type 2 Diabetes Mellitus
  • SGLT2 inhibitor
  • Seoul, Seodaemun-gu, Korea, Republic of
    Severance Hospital
Nov 17, 2023

Ovarian Cancer Trial (JPI-547)

Not yet recruiting
  • Ovarian Cancer
  • (no location specified)
Jul 24, 2022

PIK3CA Mutation-Related Tumors Trial in Shanghai (WX390)

Completed
  • PIK3CA Mutation-Related Tumors
  • Shanghai, Shanghai, China
    Shanghai East Hospital
Nov 9, 2023

Solid Tumor, Non-Hodgkin's Lymphoma Trial in China, Taiwan (ATG-019, ATG-019 + Niacin ER)

Recruiting
  • Solid Tumor, Non-Hodgkin's Lymphoma
  • Nanjing, Jiangsu, China
  • +7 more
Aug 11, 2022

Refractory Soft Tissue Sarcomas Trial run by the NCI (Cabozantinib)

Active, not recruiting
Has Results
  • Refractory Soft Tissue Sarcomas
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 5, 2022

Acute Coronary Syndrome Trial in São Paulo (Dual antiplatelet therapy: Acetylsalicylic acid + ticagrelor OR Acetylsalicylic acid

Recruiting
  • Acute Coronary Syndrome
  • Dual antiplatelet therapy: Acetylsalicylic acid + ticagrelor OR Acetylsalicylic acid + prasugrel
  • Monotherapy: Ticagrelor alone OR Prasugrel alone
  • São Paulo, Brazil
    Hospital Israelita Albert Einstein
Mar 2, 2023

Castrate Resistant Prostate Cancer, NUT Carcinoma Trial (EP31670)

Not yet recruiting
  • Castrate Resistant Prostate Cancer
  • NUT Carcinoma
  • (no location specified)
Aug 3, 2022

Cicatricial Alopecia Trial in New York (PF-06700841, Placebo)

Recruiting
  • Cicatricial Alopecia
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Aug 16, 2022

Left Main Coronary Artery Stenosis Trial in Geneva (LMCA PCI with Biofreedom Ultra drug-coated stent (Biosensors International,

Not yet recruiting
  • Left Main Coronary Artery Stenosis
  • LMCA PCI with Biofreedom Ultra drug-coated stent (Biosensors International, Switzerland)
  • +2 more
  • Geneva, Switzerland
    Geneva University Hospitals
Jan 12, 2023

Advanced Solid Tumors Trial in Seongnam-si, Seoul (JPI-547)

Completed
  • Advanced Solid Tumors
  • Seongnam-si, Gyeonggi-do, Korea, Republic of
  • +1 more
Jun 1, 2022

Metastatic Breast Cancer, Solid Tumors Trial in Aurora (Alisertib, MLN0128)

Completed
Has Results
  • Metastatic Breast Cancer
  • Solid Tumors
  • Aurora, Colorado
    University of Colorado Cancer Center
May 17, 2022

Leukemia, Brain Tumor, Solid Tumor Trial in United States (ALRN-6924, Cytarabine)

Recruiting
  • Leukemia
  • +3 more
  • San Francisco, California
  • +3 more
Jun 14, 2022

Unifying Advanced Treatment With Advanced Imaging

Completed
  • Gastrointestinal Stromal Tumor (GIST)
  • Dual Energy CT
  • Mannheim, Germany
    University Center Mannheim
Apr 6, 2022

Metastatic Melanoma, Skin Cancer Trial in Boston (Ipilimumab, Nivolumab, Cryoablation)

Not yet recruiting
  • Metastatic Melanoma
  • Skin Cancer
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Mar 9, 2023

Coronary Artery Disease Trial in Jacksonville (aspirin plus clopidogrel, prasugrel or ticagrelor)

Not yet recruiting
  • Coronary Artery Disease
  • aspirin plus clopidogrel
  • prasugrel or ticagrelor
  • Jacksonville, Florida
    University of Florida
Jan 4, 2023

Pancreatic Ductal Adenocarcinoma Trial (JPI-547, modified FOLFIRINOX, Gemcitabine-nab-paclitaxel)

Not yet recruiting
  • Pancreatic Ductal Adenocarcinoma
  • (no location specified)
Feb 16, 2022

Solid Tumors, NHL Trial in Canada, United States (KPT-9274, Niacin ER, Nivolumab)

Terminated
  • Solid Tumors
  • NHL
  • Los Angeles, California
  • +7 more
Jan 18, 2023

Dual Antiplatelet Therapy, Acute Coronary Syndrome, Coronary Artery Disease Trial in Messina, Rivoli (P2Y12 inhibitor

Not yet recruiting
  • Dual Antiplatelet Therapy
  • +2 more
  • P2Y12 inhibitor de-escalation
  • Messina, Italy
  • +1 more
Jun 12, 2023

ST Elevation Myocardial Infarction Trial in Geneva (Successful primary PCI, defined as primary PCI of the culprit lesion with =1

Not yet recruiting
  • ST Elevation Myocardial Infarction
  • Successful primary PCI, defined as primary PCI of the culprit lesion with ≥1 Abluminus NP polymer-free sirolimus-based nanocarrier eluting stent (Concept Medical Inc., India) implantation
  • Geneva, Switzerland
    Geneva University Hospitals
Mar 25, 2023

Helicobacter Pylori Infection Trial in Taipei (High-dose dual therapy (rabeprazole, amoxicillin), Bismuth High-dose dual therapy

Recruiting
  • Helicobacter Pylori Infection
  • High-dose dual therapy (rabeprazole, amoxicillin)
  • +2 more
  • Taipei, Taiwan
    National Taiwan University Hospital
Jan 18, 2022

Breast Cancer Trial in Los Angeles, Bronx (Gedatolisib, Faslodex, Palbociclib)

Active, not recruiting
  • Breast Cancer
  • Los Angeles, California
  • +1 more
Jan 25, 2022

Endometrioid Cancer, Mucinous Ovarian Cancer, High Grade Serous Ovarian Cancer Trial in Oklahoma City (VS-6766 + defactinib)

Not yet recruiting
  • Endometrioid Cancer
  • +3 more
  • VS-6766 + defactinib
  • Oklahoma City, Oklahoma
    Stephenson Cancer Center
Aug 19, 2022

Healthy Volunteers Trial in Austin (Fedratinib, Fluconazole)

Completed
  • Healthy Volunteers
  • Austin, Texas
    PPD Phase 1 Clinic
Nov 17, 2021

Stable Angina, Unstable Angina, Non-ST Segment Elevation Myocardial Infarction Trial in Korea, Republic of (CX-ISAR, Orsiro,

Completed
  • Stable Angina
  • +2 more
  • 3-months DAPT
  • 1-year DAPT
  • Busan, Korea, Republic of
  • +11 more
Jan 8, 2023

Benign Prostatic Hyperplasia (BPH) Trial in France (REZUM, alpha blocker and 5-alpha reductase inhibitor)

Recruiting
  • Benign Prostatic Hyperplasia (BPH)
  • REZŪM
  • alpha blocker and 5-alpha reductase inhibitor
  • Aix-en-Provence, France
  • +9 more
Jul 26, 2022